A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548

Conference Paper

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Cited Authors

Weller, M; Vlahovic, G; Khasraw, M; Brandes, AA; Zwirtes, R; Tatsuoka, K; Carpentier, AF; Reardon, DA; Bent, M

Published Date

October 1, 2016

Published In

Annals of Oncology

Volume / Issue

27 /

Start / End Page

vi113 -

Electronic International Standard Serial Number (EISSN)

1569-8041

International Standard Serial Number (ISSN)

0923-7534

Digital Object Identifier (DOI)

10.1093/annonc/mdw367.34

Citation Source

Scopus